[New neuroleptics--better effects or better marketing?].
Lindefors
N
N
Karolinska institutet, Psykiatri Centrum Karolinska, Stockholm. nils.lindefors@cns.ki.se
D000329:Advertising; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D016527:Drug Costs; D004346:Drug Information Services; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D006801:Humans; D015201:Meta-Analysis as Topic
D014150:Antipsychotic Agents; D006220:Haloperidol